rs587778583
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM4
The NM_024675.4(PALB2):c.1882_1890delAAGTCCTGC(p.Lys628_Cys630del) variant causes a conservative inframe deletion change. The variant allele was found at a frequency of 0.0000185 in 1,461,884 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_024675.4 conservative_inframe_deletion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000319 AC: 8AN: 250874Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135850
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1461884Hom.: 0 AF XY: 0.0000234 AC XY: 17AN XY: 727242
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Uncertain:3
This variant causes an in-frame deletion of three amino acids in the PALB2 protein. To our knowledge, functional studies have not been reported for this variant. This variant has been reported two individuals each affected with breast cancer and gastric cancer (PMID: 28024868, 28779002) and two individuals unaffected with breast cancer (PMID: 28779002) and a healthy individual (PMID: 24728327). This variant has been identified in 8/250874 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
The c.1882_1890delAAGTCCTGC variant (also known as p.K628_C630del) is located in coding exon 5 of the PALB2 gene. This variant results from an in-frame AAGTCCTGC deletion at nucleotide positions 1882 to 1890. This results in the in-frame deletion of 3 amino acid residues at codons 628 to 630. This alteration has been reported in at least one breast cancer patient in a study of 13087 breast cancer cases and 5488 control individuals in the UK (Decker B et al. J Med Genet, 2017 11;54:732-741). This alteration was also identified in two individuals diagnosed with gastric cancer (Sahasrabudhe R et al. Gastroenterology 2017 Apr;152(5):983-986.e6). This region is not well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Based on the available evidence, the clinical significance of this alteration remains unclear. -
- -
Familial cancer of breast Uncertain:2
This variant, c.1882_1890del, results in the deletion of 3 amino acid(s) of the PALB2 protein (p.Lys628_Cys630del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs587778583, gnomAD 0.005%). This variant has been observed in individual(s) with PALB2-related conditions (PMID: 28024868, 34359559). ClinVar contains an entry for this variant (Variation ID: 134993). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
not specified Uncertain:1Other:1
- -
Variant summary: PALB2 c.1882_1890delAAGTCCTGC (p.Lys628_Cys630del) results in an in-frame deletion that is predicted to remove three amino acids from the encoded protein. The variant allele was found at a frequency of 3.2e-05 in 250874 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.1882_1890delAAGTCCTGC has been reported in the literature in individuals affected gastric cancer (example: Sahasrabudhe_2017). This report does not provide unequivocal conclusions about association of the variant with Hereditary Breast And Ovarian Cancer Syndrome. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Four clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014and all laboratories classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. -
Familial cancer of breast;C1835817:Fanconi anemia complementation group N;C3150547:Pancreatic cancer, susceptibility to, 3 Uncertain:1
- -
not provided Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at